Clinical policies and procedures

Clinical policies and procedures
Informed Consent for Transfusion - NZBS Policy (111P005) (pdf, 24 KB)
Consent for Use of Blood Products (111F131) (pdf, 58 KB)
NZBS Dispensing Policy (111P001) (pdf, 260 KB)
Dispensing of Interchangeable Blood Products (111D003) (pdf, 158 KB)
Directed Donations - NZBS Policy (111P066) (pdf, 32 KB)
Agreement to Provide Directed Blood Donation(s) (111F066a) (pdf, 18 KB)
Consent of Recipient/Parent/Guardian to Accept Directed Blood Donation(s) (111F066b) (pdf, 51 KB)
Distribution and Supply of Plasma Derived Fractionated Blood Products and Recombinant Products in New Zealand (160P002) (pdf, 491 KB)
List of Fractionated Products and Recombinant Products Approved for Distribution (111D132) (pdf, 200 KB)
NZBS Terms and Conditions relating to the Issue of Non-Conforming Products on Clinical Grounds (111P019) (pdf, 83 KB)
Release of Non-Conforming Products for Use in a Designated Patient on Clinical Grounds (111M019) (pdf, 157 KB)
Request from Treating Clinician for Exceptional Release of Non-Conforming Product (111F019) (pdf, 105 KB)
Request for Blood Bank Tests and Blood Components or Products (111F018) (pdf, 199 KB)
Recording and Reporting the Supply of Unapproved Medicines under Section 29 of the Medicines Act (108M020) (pdf, 149 KB)
Medsafe Declaration/Notification Form for Medicines Supplied Pursuant to Section 29 of the Medicines Act 1981 (108E001) (pdf, 76 KB)
Unapproved Medicine Record (108F064) (pdf, 115 KB)
Transfusion-related Adverse Reaction Notification Form (111F009) (pdf, 561 KB)
Managing Notification of Adverse Reactions to Fractionated Blood Products (111M003) (pdf, 281 KB)
Notification of Suspected Adverse Reaction to a Fractionated Blood Product (111F003) (pdf, 211 KB)
Clinical Follow Up of Platelets Returning Initial Positive Results for Bacterial Contamination (111M012) (pdf, 176 KB)
Exceptional Release of Non-Conforming Platelet Component (111F024) (pdf, 237 KB)
CSL Product Complaint Process Flowchart (111D135) (pdf, 94 KB)
Blood Component Support of Rh(D) Negative Individuals (111P032) (pdf, 288 KB)
NZBS Policy on the Use of Fresh Blood (111P074) (pdf, 142 KB)
NZBS Policy on the Provision of CMV Antibody Negative Blood Components (111P067) (pdf, 115 KB)
Notification of a Special Blood Component Requirement (111F047) (pdf, )
Policy for Collection and Transfusion of Granulocytes (111P049) (pdf, 71 KB)
Policy for the Documentation of Procedural Information for Therapeutic Apheresis Procedures (111P056) (pdf, 32 KB)
NZBS Policy on Collection and Cryopreservation of Haematopoietic Progenitor Cell (HPC), Cord Blood (HPC, Cord Blood) for Directed HPC Transplantation (111P007) (pdf, 149 KB)
Haemovigilance Policy (111P010) (pdf, 209 KB)
Management of Clinical Requests for Non-Standard Blood Components (111P011) (pdf, 128 KB)
Request Form for a Non-Standard Component (111F054) (pdf, 126 KB)
Exceptional Release of Non-Conforming Product (111M109) (pdf, 157 KB)

You may need to download Adobe Reader to view the PDF files. It is available free from the Adobe site(external link).

Back to top

Subscribe